Investment focus and strategy
The investment focus of CapMan Life Science is on medical technology and healthcare services.
Where do we invest?
- primarily Nordic companies and selectively the rest of Europe
- the products or services of our portfolio companies satisfy direct and long-term customer demands, and typically enable better treatment outcome at a lower cost.
- net sales between €2–20 million
- investment size typically €2–7 million equity (Life Science funds)
What do we look for?
-
a proven business model and approved products/services
-
significant domestic or international growth potential, organically or via add-on acquisitions
-
–an experienced, entrepreneurial executive team